Broken redirects

The following redirects link to non-existent pages:

Showing below up to 250 results in range #1 to #250.

1. Bangui definition → 1985 World Health Organization AIDS surveillance case definition
2. C21-hydroxylase deficiency → 21-Hydroxylase Deficiency
3. Steroid 21-hydroxylase deficiency → 21-Hydroxylase Deficiency
4. Steroid 21-monooxygenase deficiency → 21-Hydroxylase Deficiency
5. MAVErIC II → 30-Day Results From A Prospective Registry Of Carotid Stenting With The Exponent Stent And Distal Protection With The Guardwire In High Risk Patients
6. 48,XXYY syndrome → 48 XX,YY
7. 48 xxyy syndrome → 48 XX,YY
8. ACT-UP → AIDS Coalition to Unleash Power
9. ASTM → ASTM International
10. ABSORB: 6-month and 2-year results → A Bioabsorbable Everolimus-Eluting Coronary Stent System For Patients With Single De-Novo Coronary Artery Lesions
11. PREPIC → A Clinical Trial Of Vena Caval Filters In The Prevention Of Pulmonary Embolism In Patients With Proximal Deep-Vein Thrombosis
12. Comparison of Ibuprofen and Indomethacin for Closure of Patent Ductus Arteriosus → A Comparison Of Ibuprofen And Indomethacin For Closure Of Patent Ductus Arteriosus
13. THESEE → A Comparison Of Low-Molecular-Weight Heparin With Unfractionated Heparin For Acute Pulmonary Embolism
14. TOPAS → A Comparison Of Recombinant Urokinase With Vascular Surgery As Initial Treatment For Acute Arterial Occlusion Of The Legs
15. CRIS → A Controlled Trial Of Verapamil In Patients After Acute Myocardial Infarction: Results Of The Calcium, Antagonist Reinfarction Italian Study
16. ACCENT → A Crohn's Disease Clinical Trial Evaluating Infliximab In A New Long-Term Treatment Regimen
17. AGENT-3 → A Multicenter, Prospective, Randomized Trial Of Intracoronary Administration Of Ad5Fgf-4 In Patients With No Revascularization Options
18. MINT → A Multicenter, Randomized Study Of Argatroban Versus Heparin As Adjunct To Tissue Plasminogen Activator (Tpa) In Acute Myocardial Infarction: Myocardial Infarction With Novastan And Tpa (Mint) Study
19. AMAZE → A Multicenter Trial Using-Zestril Versus To Evaluate The Effects On Lowering Blood Pressure
20. PRIDE → A Prospective, Randomized, Controlled Trial Of Distal Protection With The Kensey-Nash Triactiv System Compared To The Guardwire Or Filterwire
21. CAPTIVE → A Prospective, Randomized, Controlled Trial Of Distal Protection With The Third Generation Mednova Emboshield Compared To The Guardwire Or Filterwire
22. DIABETES → A Prospective, Randomized, Controlled Trial Of The Polymer-Based, Sirolimus-Eluting Stent Versus A Bare Metal Stent In Patients With Diabetes Mellitus
23. AiMI → A Prospective, Randomized, Controlled Trial Of Thrombectomy With The Angiojet In Acute Myocardial Infarction
24. RACTS → A Prospective, Randomized Multicenter Trial Of Cilostozal Vs Ticlopidine In Patients Undergoing Stent Implantation
25. REDUCE III → A Prospective, Randomized Multicenter Trial Of Cutting Balloon Before Stenting In Patients Undergoing Pci
26. SYMBIOT III → A Prospective, Randomized Trial Of A Self-Expanding Ptfe Stent Graft During Svg Intervention - Late Results
27. SYNERGY-PCI → A Prospective, Randomized Trial Of Enoxaparin And Unfractionated Heparin In Patients With Acute Coronary Syndromes - Results In Patients Undergoing Percutaneous Coronary Intervention
28. GENESIS → A Randomized, Multicenter Study Of The Pimecrolimus-Eluting And Pimecrolimus/Paclitaxel-Eluting Coronary Stent System In Patients With De Novo Lesions Of The Native Coronary Arteries
29. RAVEL → A Randomized Comparison Of A Sirolimus-Eluting Stent With A Standard Stent For Coronary Revascularization
30. GENIUS-STEMI → A Randomized Comparison Of Genous Stent Versus Chromium-Cobalt Stent For Treatment Of St-Elevation Myocardial Infarction
31. DES-DIABETES → A Randomized Comparison Of Sirolimus- Versus Paclitaxel-Eluting Stent Implantation In Patients With Diabetes Mellitus
32. ADVANCE → A Randomized Comparison Of The Value Of Additional Stenting After Optimal Balloon Angioplasty For Long Coronary Lesions
33. RIO-Europe → A Randomized Double-Blind Study Of Weight Reducing Effect And Safety Of Rimonabant In Obese Patients With Or Without Comorbidities
34. SPIRIT → A Randomized Trial Of Anticoagulants Versus Aspirin After Cerebral Ischemia Of Presumed Arterial Origin
35. STAR → A Randomized Trial Of Recombinant Staphylokinase Versus Altepase For Coronary Artery Patency In Acute Myocardial Infarction
36. SMARTT → A Randomized Trial Of The Effects Of Early Cardiac Serum Marker Availability On Reperfusion Therapy In Patients With Acute Myocardial Infarction. The Serial Markers, Acute Myocardial Infarction And Rapid Treatment Trial (Smartt)
37. INTERHEART → A Study Of Risk Factors For First Myocardial Infarction In 52 Countries And Over 27,000 Subjects
38. ASTEROID → A Study To Evaluate The Effect Of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden
39. AURORA → A Study To Evaluate The Use Of Rosuvastatin In Subjects On Regular Hemodialysis: An Assessment Of Survival And Cardiovascular Events
40. Tubulidentata → Aardvark
41. Aaron Beck → Aaron Temkin Beck
42. AbESTT → Abciximab Emergent Stroke Treatment Trial
43. APAF → Ablation For Paroxysmal Atrial Fibrillation (Apaf) Trial
44. Abraham De Moivre → Abraham de Moivre
45. Abulcasis → Abu al-Qasim al-Zahrawi
46. Al-Zahrawi → Abu al-Qasim al-Zahrawi
47. ACTIVATE → Acat Inhibition On The Progression Of Coronary Atherosclerosis
48. Access Site Complications → Access site complications
49. ASTRONAUT → Acid Suppression Trial: Ranitidine Zantac Versus Omeprazole
50. Acinetobacter spp → Acinetobacter
51. ATLAS - SVG → Acolysis During Treatment Of Lesions Affecting Saphenous Vein Bypass Grafts
52. Acquired pure megakaryocytic aplasia → Acquired pure red cell aplasia
53. ASCENT → Acs Stent Clinical Equivalence In De Novo Lesions Trial
54. ACTIV in CHF → Acute And Chronic Therapeutic Impact Of A Vasopressin 2 Antagonist (Tolvaptan) In Congestive Heart Failure
55. ACCESS → Acute Candesartan Cilexetil Evaluation In Stroke Survivors
56. ACUITY Timing Trial → Acute Catheterization And Urgent Intervention Triage Strategy Timing Trial
57. ACUITY PCI: 30-day and 1-Year Results → Acute Catheterization And Urgent Intervention Triage Strategy Trial - Pci Subgroup: 30-Day And 1-Year Results
58. AIRE → Acute Infarction Ramipril Efficacy Study
59. AIST-ASH → Acute Ischemic Stroke Trial: Oral Aspirin Vs Intravenous Heparin On Stroke Progression
60. AMISTAD → Acute Myocardial Infarction Study Of Adenosine
61. AMISTAD II → Acute Myocardial Infarction Study Of Adenosine II
62. AMISTAD I → Acute Myocardial Infarction Study Of Adenosine Trial
63. AMIHOT → Acute Myocardial Infarction With Hyperoxemic Therapy
64. AMIHOT II → Acute Myocardial Infarction With Hyperoxemic Therapy II
65. Acute biphenotypic leukemia → Acute biphenotypic leukaemia
66. FEMINA → Addition Of Felodipine To Metoprolol Vs. Replacement Of Metoprolol By Felodipine In Patients With Angina Pectoris Despite Adequate Beta-Blockade
67. Adenoid cystic cancer → Adenoid cystic carcinoma
68. Adenocyst → Adenoid cystic carcinoma
69. Malignant cylindroma → Adenoid cystic carcinoma
70. Adenocystic carcinoma → Adenoid cystic carcinoma
71. Adenoidcystic carcinoma → Adenoid cystic carcinoma
72. Cribriform Carcinoma → Adenoid cystic carcinoma
73. Toxic thyroid adenoma → Adenoma of the thyroid
74. INSPIRE → Adenosine Sestamibi Post-Infarction Evaluation (Inspire) Trial
75. ADEMEX → Adequacy Of Peritoneal Dialysis In Mexico
76. ABACAS → Adjunctive Balloon Angioplasty Following Coronary Atherectomy Study
77. Adolf Windaus → Adolf Otto Reinhold Windaus
78. Adrien Marie Legendre → Adrien-Marie Legendre
79. AGIS → Advanced Glaucoma Intervention Study
80. Advocacy → Advocate
81. AIR → Aerosolized Iloprost Randomized Placebo-Controlled Study
82. A-HeFT → African-American Heart Failure Trial
83. A to Z, Phase A → Aggrastat To Zocor
84. AtoZ → Aggrastat To Zocor Study
85. Aggressiveness → Aggression
86. ALLIANCE → Aggressive Lipid-Lowering Initiation Abates New Cardiac Events
87. ARISE → Aggressive Reduction Of Inflammation Stops Events
88. Intermediate-grade lymphoma → Aggressive lymphoma
89. High-grade lymphoma → Aggressive lymphoma
90. Aging in Place → Aging in place
91. Redtop grass → Agrostis gigantea
92. Alcoholic beverages → Alcoholic beverage
93. Aldactone Antagonists → Aldactone antagonist
94. Lemtrada → Alentuzumab
95. Immortality Device → Alex Chiu
96. Edmé Félix Alfred Vulpian → Alfred Vulpian
97. ALLAY → Aliskiren In Left Ventricular Hypertrophy
98. AVOID → Aliskiren In The Evaluation Of Proteinuria In Diabetes
99. ALOFT → Aliskiren Observations Of Heart Failure Treatment
100. ATBC → Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study
101. AlphaPharm → Alphapharm
102. ATLANTIS → Alteplase Thrombolysis For Acute Noninterventional Therapy In Ischemic Stroke
103. ABCD → Alternans Before Cardioverter Defibrillator
104. AEGIS → Alternative Graft Investigational Study
105. ADCS → Alzheimer's Disease Cooperative Study
106. ARIES 1 and 2 → Ambrisentan In Pulmonary Arterial Hypertension Efficacy Study 1 And 2
107. AAFP → American Academy of Family Physicians
108. ACC AMI GAP → American College Of Cardiology Acute Myocardial Infarction Guidelines Applied To Practice Study
109. Journal of the American College of Cardiology → American College of Cardiology
110. ACC → American College of Cardiology
111. J. Am. Med. Assoc. → American Medical Association
112. Amiodarone overdose → AmiodaroneI#Overdosage
113. ALIVE (amio vs. lidocaine → Amiodarone As Compared With Lidocaine For Shock-Resistant Ventricular Fibrillation
114. ARCH → Amiodarone Reduction In Coronary Heart Trial
115. AMIOVIRT → Amiodarone Versus Implantable Defibrillator In Patients With Nonischemic Cardiomyopathy And Asymptomatic Nonsustained Ventricular Tachycardia Study
116. AMRO → Amsterdam-Rotterdam Trial
117. Amyotrophic lateral sclerosis diagnostic evaluation → Amyotrophic lateral sclerosis other diagnostic studies
118. Anal-oral contact → Anal-oral sex
119. Anal intercourse → Anal sex
120. Andersen cardiodysrhythmic periodic paralysis → Andersen–Tawil syndrome
121. Andreas Grüntzig → Andreas Gruentzig
122. Andrew Z. Fire → Andrew Fire
123. Androgyne → Androgyny#Androgyne
124. Androgynous → Androgyny
125. Andre Frederic Cournand → André Frédéric Cournand
126. Andre Malraux → André Malraux
127. André Lwoff → André Michel Lwoff
128. Andre Lwoff → André Michel Lwoff
129. ASIS → Angina And Silent Ischemia Study
130. ATLANTIC → Angina Treatments - - Lasers And Normal Therapies In Comparison
131. AWESOME → Angina With Extremely Serious Operative Mortality Evaluation
132. AGENT → Angiogenic Gene Therapy
133. AGENT-2 → Angiogenic Gene Therapy Trial 2
134. STARC → Angioplasty/Atherectomy/Laser Therapy: Trapidil (Triazolopyrimidine), A Platelet-Derived Growth Factor Antagonist, Reduces Restenosis After Percutaneous Transluminal Coronary Angioplasty: Results Of The Randomized, Double-Blind Starc Study
135. ASTRAL → Angioplasty And Stenting For Renal Artery Lesions
136. ACME → Angioplasty Compared To Medicine
137. ACME-2 → Angioplasty Compared To Medicine - Two-Vessel Disease
138. ARTIST → Angioplasty Versus Rotational Atherectomy For Treatment Of Diffuse In-Stent Restenosis Trial
139. ARTISTIC → Angiorad Radiation Therapy For In-Stent Restenosis Intracoronary
140. APRES → Angiotensin-Converting Enzyme Inhibition Post Revascularization Study
141. AACHEN → Angiotensin II Receptor Blocker Candesartan Cilexetil On Intimal Hyperplasia After Coronary Stent Implantation
142. ASCOT → Anglo-Scandinavian Cardiac Outcome Trial
143. ASCOT - Blood Pressure Arm → Anglo-Scandinavian Cardiac Outcomes Trial: Blood Pressure-Lowering Arm
144. ASSET → Anglo-Scandinavian Study Of Early Thrombolysis
145. Vessel tortuosity → Angulation and tortuosity
146. Tortuous vessel → Angulation and tortuosity
147. Animals → Animal
148. Animalia → Animal
149. Metazoa → Animal
150. Anthrax Vaccine Adsorbed → Anthrax vaccine
151. Anthrax vaccine adsorbed → Anthrax vaccine
152. AVA → Anthrax vaccine
153. APLAUSE → Anti-Platelet Treatment After Intravascular Ultrasound Guided Optimal Stent Expansion
154. ATTACH → Anti-Tnf Therapy Against Congestive Heart Failure Trial
155. ATTRACT → Anti-Tnf Trial In Rheumatoid Arthritis With Ca2 Treatment
156. ATLAS-TIMI 46 → Anti-Xa Therapy To Lower Cardiovascular Events In Addition To Aspirin With Or Without Thienopyridine In Subjects With Acute Coronary Syndromes–Thrombolysis In Myocardial Infarction 46
157. ADIOS → Antiarrhythmic Drug Improve Outcome Study
158. ANTIBIO → Antibiotic Therapy After An Acute Myocardial Infarction
159. ATBAT → Anticoagulant Therapy With Bivalirudin To Assist In Pci 1St Inning Trial (Pci In Hit/Hitts)
160. ANTHEM–TIMI-32 → Anticoagulation With Rnapc2 To Eliminate Mace/Timi 32
161. ATICH → Antifibrinolytic Therapy In Acute Intracerebral Hemorrhage
162. APASS → Antiphospholipid Antibody Stroke Study
163. ATLAST → Antiplatelet Therapy Alone Versus Lovenox Plus Antiplatelet Therapy In Patients At Increased Risk Of Stent Thrombosis
164. ARMYDA-RELOAD → Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty-Reload
165. ARMYDA-2 → Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 2
166. ARMYDA-3 → Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 3
167. ARMYDA-4 → Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 4
168. ARMYDA-5 → Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 5
169. STAI → Antiplatelet Treatment With Ticlopidine In Unstable Angina (Studio Della Ticlopidine Nell'Angina Instabile)
170. AT LAST → Antiretroviral Trial Looking At Sex And Treatment
171. APRICOT → Antithrombotics In The Prevention Of Reocclusion In Coronary Thrombolysis
172. APRICOT-2 → Antithrombotics In The Prevention Of Reocclusion In Coronary Thrombolysis-2
173. Lavoisier → Antoine Lavoisier
174. Anton van Leeuwenhoek → Antonie van Leeuwenhoek
175. Antoine van Leeuwenhoek → Antonie van Leeuwenhoek
176. Antonio Caetano De Abreu Freire Egas Moniz → António Egas Moniz
177. Hysterical neurosis → Anxiety disorder
178. Anxiety-tension syndrome → Anxiety disorder
179. ASSERT → Aortic Stentless Versus Stented Valve Assessed By Echocardiography Randomized Trial
180. ACRE → Appropriateness Of Coronary Revascularization
181. AIMS → Apsac Intervention Mortality Study
182. ARMS → Apsac Reocclusion Multicenter Study
183. ALKK → Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte
184. ARG-911 → Argatroban-911
185. ARG-915 → Argatroban-915
186. ARGAMI-2 → Argatroban For Acute Myocardial Infarction
187. ERACI II → Argentine Randomized Study: Coronary Angioplasty With Stenting Vs. Coronary Artery Bypass Surgery In Patients With Multiple-Vessel Disease (Eraci II): 30-Day And One Year Follow-Up Results
188. ATAC → Arimidex (Anastrozole), Tamoxifen And Combination Therapy
189. ASPIRE → Arixtra Study In Percutaneous Coronary Intervention: A Randomized Evaluation
190. AFREGS → Armed Forces Regression Study
191. Army Nurse Corps (United States) → Army Medical Department (United States)#Army Nurse Corps
192. ASSURE → Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit Of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter Defibrillator Implantations
193. Mugwort → Artemisia vulgaris
194. Mugwort tree → Artemisia vulgaris
195. ARBITER 2 → Arterial Biology For The Investigation Of The Treatment Effects Of Reducing Cholesterol 2
196. ADMIT → Arterial Disease Multiple Intervention Trial
197. ARTS → Arterial Revascularization Therapies Study
198. ARTS-II → Arterial Revascularization Therapies Study Part II: Sirolimus-Eluting Stents For The Treatment Of Patients With Multivessel De Novo Coronary Artery Lesions
199. Arthritis echocardiography or ultrasound → Arthritis ultrasound
200. Arthritis chest x ray → Arthritis x ray
201. ACE (Carotid Endarterectomy) → Asa And Carotid Endarterectomy Trial
202. Asklepios → Asclepius
203. ALTS → Ascus/Lsil Triage Study
204. Aseptic meningitis laboratory tests → Aseptic meningitis laboratory findings
205. Asexual → Asexuality
206. ASPAC → Asian-Pacific Collaboration On Chd Risk Factor Intervention
207. Erwinaze → Asparaginase Erwinia Chrysanthemi
208. ASPECT-2 → Aspirin And Coumadin After Acute Coronary Syndromes (The Aspect-2) Study: A Randomised Controlled Trial.
209. ADONIS → Aspirin Dose Optimized In Noncardioembolic Ischemic Stroke
210. AVASIS → Aspirin Versus Anticoagulants In Symptomatic Intracranial Stenosis
211. ACCURACY → Assessment By Coronary Computed Tomographic Angiography Of Individuals Undergoing Invasive Coronary Angiography
212. ACORN → Assessment Of A Cardiac Support Device (Csd) In Patients With Heart Failure
213. ACUTE → Assessment Of Cardioversion Using Transesophageal Echocardiography
214. ACUTE II → Assessment Of Cardioversion Using Transesophageal Echocardiography
215. ADVENT → Assessment Of Diabetes Control And Evaluation Of The Efficacy Of Niaspan Trial
216. ASSIST → Assessment Of Implementation Strategies
217. ALERT → Assessment Of Lescol In Renal Transplantation
218. APEX AMI → Assessment Of Pexelizumab In Acute Myocardial Infarction
219. ALBION → Assessment Of The Best Loading Dose Of Clopidogrel To Blunt Platelet Activation, Inflammation, And On-Going Necrosis
220. AMEthyst → Assessment Of The Medtronic Ave Interceptor Saphenous Vein Graft Filter System
221. ASSENT-2 → Assessment Of The Safety And Efficacy Of A New Thrombolytic: Tnk-Tpa-2
222. ASSENT 3 PLUS → Assessment Of The Safety And Efficacy Of A New Thrombolytic Regimen-3
223. ASSENT-4 PCI → Assessment Of The Safety And Efficacy Of A New Treatment Strategy For Acute Myocardial Infarction
224. ASSENT-1 → Assessment Of The Safety Of A New Thrombolytic: Tnk-Tpa
225. ATLAS → Assessment Of Treatment With Lisinopril And Survival
226. APPROACH → Assessment On The Prevention Of Progression By Rosiglitazone On Atherosclerosis In Diabetes Patients With Cardiovascular History
227. Assessment of Severity of MS → Assessment of severity of Mitral stenosis
228. ABC study → Association Of Black Cardiologists Study Of Hypertension
229. AAMI → Association for the Advancement of Medical Instrumentation
230. ASTAMI → Astami
231. Sir Astley Paston Cooper → Astley Cooper
232. Astrocytoma other imaging findings → Astrocytoma imaging findings
233. ACIP → Asymptomatic Cardiac Ischemia Pilot Study
234. ACAS → Asymptomatic Carotid Atherosclerosis Study
235. ACST → Asymptomatic Carotid Surgery Trial
236. ASFAST → Atherosclerosis And Folic Acid Supplementation Trial
237. ARIC → Atherosclerosis Risk In Communities
238. C-PORT → Atlantic Cardiovascular Patient Outcomes Research Team Trial
239. ARMYDA → Atorvastatin For Reduction Of Myocardial Damage During Angioplasty
240. ARMYDA-ACS → Atorvastatin For Reduction Of Myocardial Damage During Angioplasty-Acute Coronary Syndromes
241. ARMYDA-RECAPTURE → Atorvastatin For Reduction Of Myocardial Damage During Angioplasty-Recapture
242. ATHEROMA → Atorvastatin Therapy: Effects Of Reduction Of Macrophage Activity
243. ADOPT → Atrial Dynamic Overdrive Pacing Trial
244. ADOPT-A → Atrial Dynamic Overdrive Pacing Trial-A
245. AFASAK → Atrial Fibrillation, Aspirin, Antikoagulation
246. AF-CHF → Atrial Fibrillation And Congestive Heart Failure
247. AFFIRM → Atrial Fibrillation Follow-Up Investigation Of Rhythm Management
248. ASTRID → Atrial Sensing Trial To Prevent Inappropriate Detections
249. ATTEST → Atrial Therapy Efficacy And Safety Trial
250. Schack August Steenberg Krogh → August Krogh